Emerald Mutual Fund Advisers Trust lessened its stake in shares of Moelis & Company (NYSE:MC - Free Report) by 16.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 301,224 shares of the asset manager's stock after selling 59,647 shares during the period. Moelis & Company makes up about 1.4% of Emerald Mutual Fund Advisers Trust's portfolio, making the stock its 18th biggest position. Emerald Mutual Fund Advisers Trust owned approximately 0.40% of Moelis & Company worth $22,254,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also bought and sold shares of MC. Virtu Financial LLC purchased a new stake in shares of Moelis & Company in the 3rd quarter valued at $633,000. SkyView Investment Advisors LLC lifted its holdings in shares of Moelis & Company by 2.2% in the 3rd quarter. SkyView Investment Advisors LLC now owns 14,166 shares of the asset manager's stock valued at $971,000 after buying an additional 300 shares during the period. Tidal Investments LLC purchased a new position in Moelis & Company during the third quarter valued at approximately $1,290,000. DGS Capital Management LLC purchased a new position in Moelis & Company during the third quarter valued at approximately $202,000. Finally, GAMMA Investing LLC boosted its position in Moelis & Company by 18.1% in the 4th quarter. GAMMA Investing LLC now owns 1,175 shares of the asset manager's stock worth $87,000 after purchasing an additional 180 shares in the last quarter. Institutional investors and hedge funds own 91.53% of the company's stock.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on MC shares. Keefe, Bruyette & Woods reiterated an "outperform" rating and issued a $92.00 target price (up from $86.00) on shares of Moelis & Company in a research note on Thursday, February 6th. Wells Fargo & Company reduced their price target on Moelis & Company from $55.00 to $50.00 and set an "equal weight" rating for the company in a report on Thursday, April 24th. StockNews.com downgraded Moelis & Company from a "buy" rating to a "hold" rating in a research note on Thursday, March 13th. JMP Securities reiterated a "market perform" rating on shares of Moelis & Company in a research note on Thursday, April 24th. Finally, Morgan Stanley lowered their price target on Moelis & Company from $70.00 to $42.00 and set an "underweight" rating on the stock in a research note on Monday, April 7th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average price target of $61.83.
View Our Latest Report on Moelis & Company
Insider Transactions at Moelis & Company
In other news, General Counsel Osamu R. Watanabe sold 5,661 shares of Moelis & Company stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $74.00, for a total value of $418,914.00. Following the sale, the general counsel now owns 6,471 shares of the company's stock, valued at $478,854. The trade was a 46.66 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kenneth Moelis sold 9,712 shares of the stock in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $74.00, for a total transaction of $718,688.00. Following the completion of the transaction, the chief executive officer now owns 209,235 shares of the company's stock, valued at $15,483,390. This represents a 4.44 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 22,721 shares of company stock valued at $1,677,017. 6.40% of the stock is currently owned by company insiders.
Moelis & Company Stock Up 2.8 %
NYSE:MC traded up $1.49 on Friday, reaching $54.90. The company's stock had a trading volume of 877,826 shares, compared to its average volume of 746,584. The firm has a market cap of $4.11 billion, a price-to-earnings ratio of 31.19 and a beta of 1.53. Moelis & Company has a 12-month low of $47.00 and a 12-month high of $82.89. The stock has a 50 day moving average price of $57.17 and a 200 day moving average price of $68.44.
Moelis & Company (NYSE:MC - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The asset manager reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.07. The business had revenue of $306.59 million for the quarter, compared to analysts' expectations of $309.67 million. Moelis & Company had a net margin of 11.39% and a return on equity of 38.49%. The business's quarterly revenue was up 41.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.22 earnings per share. Equities research analysts expect that Moelis & Company will post 2.97 EPS for the current fiscal year.
Moelis & Company Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Monday, May 5th will be paid a $0.65 dividend. The ex-dividend date of this dividend is Monday, May 5th. This represents a $2.60 annualized dividend and a dividend yield of 4.74%. Moelis & Company's dividend payout ratio (DPR) is 119.27%.
About Moelis & Company
(
Free Report)
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.
See Also

Before you consider Moelis & Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.
While Moelis & Company currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.